| Mar'19 | Sep'18 | Mar'18 | Sep'17 | |||
|---|---|---|---|---|---|---|
Revenues | ||||||
Insurance revenues | ||||||
2,120 | 2,859 | 2,744 | 3,069 | |||
Net investment income | ||||||
2,201 | 2,063 | 2,107 | 2,216 | |||
Net investment gains | ||||||
574 | - | 90 | - | |||
Net realized investment gains | ||||||
- | 214 | - | 793 | |||
Other revenues | ||||||
26 | 51 | 49 | 48 | |||
Total Revenues | ||||||
4,921 | 5,187 | 4,990 | 6,126 | |||
Benefits and expenses | ||||||
Policyholder benefits | ||||||
1,954 | 3,794 | 3,095 | 3,514 | |||
Interest credit to policyholders | ||||||
70 | - | -48 | - | |||
Interest credit to policyholders | ||||||
- | 18 | - | 215 | |||
Operating costs and expenses | ||||||
2,459 | 2,307 | 2,241 | 1,905 | |||
Amortization of deferred acquisition and sales inducement costs | ||||||
371 | 313 | 374 | 402 | |||
Taxes, licenses and fees | ||||||
189 | 173 | 197 | 162 | |||
Dividends to policyholders | ||||||
18 | 20 | 18 | 18 | |||
Total Benefits and Expenses | ||||||
5,061 | 6,625 | 5,877 | 6,216 | |||
Net loss before taxes | ||||||
-140 | -1,438 | -887 | -90 | |||
Tax expense (benefit) | ||||||
-2 | - | 3 | - | |||
Tax expense | ||||||
- | 3 | - | 5 | |||
Net loss | ||||||
-138 | -1,441 | -890 | -95 | |||
Other Comprehensive Income (Loss), net of tax: | ||||||
Unrealized holding gains (losses) arising during the period (net of tax) | ||||||
4,997 | -1,221 | -4,847 | 124 | |||
Adjustment to deferred acquisition costs (net of tax) | ||||||
-649 | 171 | 582 | 9 | |||
Other Comprehensive Income (Loss) | ||||||
4,348 | -1,050 | -4,265 | 133 | |||
Comprehensive Gain (Loss) | ||||||
4,210 | -2,491 | -5,155 | 38 | |||
Basic loss per common share | ||||||
-0.04 | -0.41 | -0.25 | -0.03 | |||
Diluted loss per common share | ||||||
-0.04 | -0.41 | -0.25 | -0.03 | |||